Mechanisms That Prevent Alzheimer’s Disease: Enzymatic Activity Plays Key Role

Friday 6 March 2009 @ 5:03 am
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

In a project involving the collaboration of several institutes, research scientists of the Johannes Gutenberg University Mainz have succeeded in gaining further insight in the functioning of endogenous mechanisms that protect against the development of Alzheimer’s disease. It was found that the activity of the enzyme α-secretase is mainly responsible for the protective effect.

More: continued here





Blood Test Predicts Chance Of Dementia

Friday 6 March 2009 @ 5:03 am
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

VIB researchers connected to the Born-Bunge Institute and the University of Antwerp have discovered that the amount of the growth factor progranulin in the blood is a predictor of Frontotemporal Dementia (FTD). Progranulin plays a major role in the survival of brain cells. People who produce less progranulin have a higher risk of contracting FTD. The researchers have developed a test for measuring the amount of progranulin in the blood and thus predicting a person’s risk.

More: continued here





Impact Of Nursing Shortage Crisis On Escalating Alzheimer Population

Friday 6 March 2009 @ 5:03 am
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

In just two short years, the first wave of baby boomers will begin to turn age 65 - the age of greatest risk for developing Alzheimer’s disease. There are an estimated 5.2 million Americans living with this fatal, degenerative disease that today has no cure. With an aging baby boomer population, as many as 16 million people may have the disease by 2050. As the prevalence of Alzheimer’s increases, so does the need for qualified nurses.

More: continued here





Discovery Of Brain Hub That Links Music, Memory And Emotion

Friday 6 March 2009 @ 5:03 am
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

We all know the feeling: a golden oldie comes blaring over the radio and suddenly we’re transported back - to a memorable high-school dance, or to that perfect afternoon on the beach with friends.

More: continued here





Intellect Neurosciences, Inc. Announces Independent Studies On Copper Binding Properties Of Its Lead Candidate OXIGON(TM)

Friday 6 March 2009 @ 4:03 am
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer’s disease (”AD”), announced today that the chemical structure of OXIGON(TM) (indole-3-propionic acid) has been independently shown to form copper complexes.

More: continued here





Staying Mentally Active But Not Prolonged TV Viewing Linked To Lower Memory Loss

Friday 6 March 2009 @ 4:03 am
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

A study to be presented at a conference in the US in late spring suggests that staying mentally active as in reading magazines, or pursuing a craft or hobby like knitting, pottery, and even playing computer games, in later life may delay or prevent memory loss: however watching too much TV does not. The study will be presented at the American Academy of Neurology’s 61st Annual Meeting, which this year takes place from 25 April to 2 May in Seattle, Washington.

More: continued here





Rice Researcher Sees Link To Cardiovascular Disease, Osteoporosis

Friday 6 March 2009 @ 4:03 am
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

A research project at Rice University has brought scientists to the brink of comprehending a long-standing medical mystery that may link cardiovascular disease, osteoporosis and perhaps even Alzheimer’s disease. And for that, we can thank the rat. The recent paper in Artery Research by Rice evolutionary biologist Michael Kohn and his team reports they have found that common rats with a genetic mutation have developed a resistance to rat poison, aka warfarin.

More: continued here





News From The American Journal Of Pathology

Friday 6 March 2009 @ 4:03 am
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

Highly Active Antiretroviral Therapy (HAART) Leads to Pulmonary Hypertension Researchers led by Dr. Changyi Chen at Baylor College of Medicine discovered that HAART contributes to pulmonary hypertension in HIV-infected patients. This report can be found in the March 2009 issue of The American Journal of Pathology. An estimated 33 million people were living with human immunodeficiency virus (HIV infection) in 2007.

More: continued here





Soybean Product Fights Abnormal Protein Involved In Alzheimer’s Disease

Friday 6 March 2009 @ 4:03 am
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

A vegan food renowned in Asia for its ability to protect against heart attacks also shows a powerful ability in lab experiments to prevent formation of the clumps of tangled protein involved in Alzheimer’s disease, scientists in Taiwan are reporting. Their study is in the Feb. 11 issue of ACS’ Journal of Agricultural and Food Chemistry, a bi-weekly publication. Rita P. Y.

More: continued here





ExonHit Therapeutics Reports Advancements In The Clinical Development Of EHT 0202, Its Phase II Drug For Alzheimer’s Disease

Friday 6 March 2009 @ 4:03 am
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

ExonHit Therapeutics (Alternext: ALEHT) is pleased to announce that clinical testing of EHT 0202, its lead compound in Alzheimer’s disease, is progressing well. Patient enrolment for the Phase IIa trial assessing EHT 0202 in patients with Alzheimer’s disease is completed. “The successful completion of patient enrolment for the Phase IIa represents an important milestone in the development of EHT 0202, and provides a clear timeline for the release of results,” stated Dr.

More: continued here





«« Previous Posts